Ruxolitinib is highly effective in steroid-resistant graft-versus-host disease: real-world data from a single center.

Spalek, Adrianna; Wieczorkiewicz-Kabut, Agata; Zielinska, Patrycja; Kopinska, Anna; Helbig, Grzegorz

Spalek, Adrianna; Wieczorkiewicz-Kabut, Agata; Zielinska, Patrycja; Kopinska, Anna; Helbig, Grzegorz.

Afiliação

Spalek A; Department of Hematology and Bone Marrow Transplantation, Faculty of Medicine in Katowice, Medical University of Silesia, Katowice, Poland. adrianna.spalek@gmail.com
Wieczorkiewicz-Kabut A; Department of Hematology and Bone Marrow Transplantation, Faculty of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
Zielinska P; Department of Hematology and Bone Marrow Transplantation, Faculty of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
Kopinska A; Department of Hematology and Bone Marrow Transplantation, Faculty of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
Helbig G; Department of Hematology and Bone Marrow Transplantation, Faculty of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

Pol Arch Intern Med ; 133(3)2023 03 29.

Article em En | MEDLINE | ID: mdl-36800797

Assuntos

Doença Enxerto-Hospedeiro; Esteroides; Humanos; Nitrilas; Pirimidinas/uso terapêutico; Doença Enxerto-Hospedeiro/tratamento farmacológico; Estudos Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esteroides / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google